Sciety invests SEK 35 million in the company Elypta, which is developing a new method for early cancer diagnosis. The Sciety network together with the Swedish venture capital fund Industrifonden, Chalmers Ventures and several of the company’s existing owners took part in the capitalization. The new capital of a total
The Sciety investment syndicate recently completed an investment of MSEK 9 in Predicare, a company that has developed RETTS––a system used by the majority of Sweden’s emergency units. The new capital will be used to expand in selected European markets and further develop the company’s product portfolio. Gothenburg-based Predicare was
During September, Predicare finalised an agreement with two new clients in Norway––a hospital and an ambulance services company. Predicare continues to grow rapidly in Norway and their RETTS© system is used by 31 out of 49 hospitals with emergency units. CEO, Mathias Myrén, says: “Predicare has signed an agreement with
This week, EMPE Diagnostics completed a new share issue of a total of SEK 9.2 million with Sciety. The company has developed a quick test for tuberculosis and the new capital will support the establishment of operations in India where tuberculosis is a major health problem. “With the new capital,
This week, Single Technologies completed a new share issue of 15 million SEK with Sciety. The company has developed a DNA sequencing solution, which makes it possible to analyse larger amounts of data faster and cheaper than before. The new capital will be used to adapt the instrument for NGS
This week, pharmaceutical company Athera Biotechnologies, completed a new share issue of SEK 55 million in which Industrifonden, Östersjöstiftelsen and the Sciety investment syndicate participated. The new capital is to be used for a clinical Phase 2 study and the company aims at being acquired by a major player after